COMMUNIQUÉS West-GlobeNewswire
-
EyeGate Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update
14/11/2017 - 14:00 -
Poseida Therapeutics Presents on the Development of Allogeneic and Autologous BCMA-Specific CAR-T Therapies at Precision: Blood Cancer Summit
14/11/2017 - 14:00 -
Actinium Pharmaceuticals Launches the AWE Program aka Actinium Warhead Enabling Program to Enable Collaborations Based on Its Actinium-225 Technology Platform
14/11/2017 - 14:00 -
Former General Mills Executive Joins Canadian Startup as Advisor
14/11/2017 - 14:00 -
Intra-Cellular Therapies Presents Data on Mechanism of Action of Lumateperone and ITI-214 at the 2017 Society for Neuroscience (SfN) Annual Meeting
14/11/2017 - 14:00 -
BioSig Technologies Adds Role of Chief Regulatory and Compliance Officer in Preparation for FDA Submission
14/11/2017 - 14:00 -
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2017 Financial Results
14/11/2017 - 14:00 -
Zogenix to Present at Stifel 2017 Healthcare Conference
14/11/2017 - 14:00 -
ProQR Prices Approximately $20 Million Underwritten Public Offering and Concurrent Registered Direct Offering of Ordinary Shares
14/11/2017 - 13:44 -
Zynerba Pharmaceuticals Reports Third Quarter 2017 Financial Results and Operational Highlights
14/11/2017 - 13:30 -
XBiotech Announces Presentation of Novel Findings for MABp1 in the Prevention of Coronary Thrombosis at the American Heart Association Scientific Sessions
14/11/2017 - 13:30 -
Cesca Therapeutics to Present at the Advanced Cell Therapy Shanghai Summit 2017
14/11/2017 - 13:30 -
Strongbridge Biopharma plc Provides Corporate Update and Reports Third Quarter 2017 Financial Results
14/11/2017 - 13:30 -
ObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update
14/11/2017 - 13:01 -
AxoGen, Inc. to Present at the 29th Annual Piper Jaffray Healthcare Conference
14/11/2017 - 13:00 -
VBL Therapeutics Announces Third Quarter 2017 Financial Results
14/11/2017 - 13:00 -
Pluristem Reports First Quarter Fiscal 2018 Corporate and Financial Highlights
14/11/2017 - 13:00 -
Loxo Oncology Announces Global Development and Commercialization Partnership with Bayer for Larotrectinib and LOXO-195
14/11/2017 - 13:00 -
Deciphera Pharmaceuticals, Inc. Announces Third Quarter 2017 Financial Results and Corporate Highlights
14/11/2017 - 13:00
Pages